Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer

by Bijlsma, M.F, Bootsma, S., Damhofer, H., Goey, K.K.H, Koopman, M., Medema, J.P, Mesker, W.E, Mol, L., Punt, C.J.A, Smits, L.J.H, ten Hoorn, S., Trinh, A., Tuynman, J.B, van Oijen, M.G.H, van Pelt, G.W, Vermeulen, L., Waasdorp, C., Zhao, L., Zlobec, I.
Published 2022